Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years

Figure 1

Treatment outcome for each study year. Response data for the 16 patients reaching Year 7. Treatment outcome according to established clinical parameters for each year of the study. ASAS20, ASAS 20% response, ASAS40, ASAS 40% response, ASAS 5/6, ASAS 5/6 response, BASDAI50, BASDAI 50% response, ASAS PR, ASAS partial remission. Shown are the response data for the 16 patients reaching Year 7 at different time points. ASAS, SpondyloArthritis international Society; BASDAI, Bath Ankylosing Spondylitis Activity Index

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us